De Brauw has advised Parcom Capital on its acquisition of ViroClinics Biosciences

Parcom Capital acquires ViroClinics Biosciences, a clinical research organisation specialized in testing anti-viral drugs and vaccines developed worldwide. Key management continues to participate in the company.
Advisors
William Blair (financial adviser Gilde), Osborne Clarke (legal adviser Gilde), PwC (financial and tax adviser Parcom)

De Brauw lead partner
Lennard Keijzer
De Brauw team
Rick van 't Wout, Claudia Priem, Jan Wytze Haanstra, Lieselotte Schijf